MEREO BIOPHARMA GROUP PL-ADR (MREO)

US5894921072 - ADR

4.54  +0.07 (+1.57%)

After market: 4.54 0 (0%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to MREO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.34. This target is 61.76% above the current price.
MREO was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MREO.
In the previous month the buy percentage consensus was at a similar level.
MREO was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 4.546.067.147.348.40 - 33.48% 57.27% 61.76% 85.02%
Up and Down Grades
Date Firm Action Rating
2024-10-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-13 Needham Reiterate Buy -> Buy
2024-07-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-20 Leerink Partners Maintains Outperform -> Outperform
2024-06-13 Baird Initiate Outperform
2024-06-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-12 Needham Maintains Buy -> Buy
2024-05-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-16 Needham Reiterate Buy -> Buy
2024-04-10 Needham Reiterate Buy -> Buy
2024-03-28 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-28 Needham Maintains Buy -> Buy
2024-03-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-08 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-08 Needham Reiterate Buy -> Buy
2023-08-23 Needham Reiterate Buy -> Buy
2023-06-06 Needham Reiterate Buy -> Buy
2023-05-26 Needham Reiterate Buy -> Buy
2023-04-21 Needham Reiterate Buy
2023-03-30 Needham Reiterate Buy
2022-11-10 SVB Leerink Maintains Outperform
2022-08-12 Cantor Fitzgerald Initiate Overweight
2022-06-06 Needham Maintains Buy
2021-05-05 BTIG Initiate Buy
2021-04-05 Needham Initiate Buy